Stifel Nicolaus Raises Mettler-Toledo International (NYSE:MTD) Price Target to $1,600.00

Mettler-Toledo International (NYSE:MTD) had its price target lifted by analysts at Stifel Nicolaus from $1,450.00 to $1,600.00 in a report released on Monday,Benzinga reports. The firm currently has a “buy” rating on the medical instruments supplier’s stock. Stifel Nicolaus’ target price indicates a potential upside of 11.95% from the company’s previous close.

Several other research analysts also recently weighed in on the stock. Bank of America upped their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Citigroup raised their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Barclays raised their target price on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Finally, JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $1,351.50.

Mettler-Toledo International Trading Down 0.7%

NYSE:MTD opened at $1,429.24 on Monday. The firm has a fifty day simple moving average of $1,320.50 and a two-hundred day simple moving average of $1,238.16. Mettler-Toledo International has a 12 month low of $946.69 and a 12 month high of $1,454.68. The stock has a market capitalization of $29.44 billion, a price-to-earnings ratio of 36.27, a PEG ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Equities analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider directly owned 94 shares in the company, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,527 shares of company stock valued at $1,994,981 in the last 90 days. 1.94% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Envestnet Asset Management Inc. boosted its holdings in shares of Mettler-Toledo International by 2.5% during the 1st quarter. Envestnet Asset Management Inc. now owns 15,823 shares of the medical instruments supplier’s stock worth $18,686,000 after buying an additional 393 shares during the period. Cerity Partners LLC boosted its stake in Mettler-Toledo International by 7.1% during the 1st quarter. Cerity Partners LLC now owns 3,643 shares of the medical instruments supplier’s stock valued at $4,302,000 after purchasing an additional 242 shares during the period. Ballentine Partners LLC grew its holdings in Mettler-Toledo International by 15.4% in the 1st quarter. Ballentine Partners LLC now owns 554 shares of the medical instruments supplier’s stock valued at $654,000 after buying an additional 74 shares during the last quarter. CWM LLC lifted its holdings in shares of Mettler-Toledo International by 2.5% during the first quarter. CWM LLC now owns 657 shares of the medical instruments supplier’s stock worth $776,000 after buying an additional 16 shares during the last quarter. Finally, Edgestream Partners L.P. grew its position in Mettler-Toledo International by 44.6% in the 1st quarter. Edgestream Partners L.P. now owns 8,431 shares of the medical instruments supplier’s stock worth $9,956,000 after purchasing an additional 2,602 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.